The following tables list on-going projects, first from EU and then from various Swedish agencies (VR, Vinnova, SSF, MSB).
EU funded projects:
TYPE
|
ACRONYM
|
YEARS
|
AMOUNT
|
ORGANIZATION
|
| FP6 |
IMATERA |
08-11 |
500 kSEK |
FOI |
| FP7:SEC |
WIMAAS |
08-11 |
314 k€ |
FOI |
| FP7:SEC |
LOTUS |
09-11 |
827 k€ |
FOI |
| FP7-PEOPLE |
McIMPULSE |
09-11 |
1000 k€ |
LiU |
| FP7:SEC |
IMSK |
09-12 |
608 k€ |
FOI |
| FP7:SEC |
ADABTS |
09-12 |
1034 k€ |
FOI |
| FP7:SIS |
ETHENTECH |
09-12 |
5000 k€ |
KTH |
| FP7:SEC |
EFFISEC |
09-14 |
1218 k€ |
FOI |
| FP7:SEC |
DECOTESSC1 |
10-13 |
124 k€ |
FOI |
| FP7:SEC |
TWOBIAS |
10-13 |
602 k€ |
FOI |
| FP7:SEC |
PREVAIL |
10-13 |
708 k€ |
FOI |
| FP7:SEC |
SUPPORT |
10-13 |
1257 k€ |
FOI |
| FP7:SEC |
SEABILLA |
10-13 |
580 k€ |
FOI |
| FP7:SEC |
EMPHASIS |
11-14 |
900 k€ |
FOI |
| FP7:SEC |
SECUR-ED |
11-14 |
750 k€ |
FOI |
| FP7:SEC |
ARENA |
11-14 |
375 k€ |
FOI |
| FP7:SEC |
CONTAIN |
11-14 |
1400 k€ |
FOI |
| FP7:SEC |
ACRIMAS |
11-14 |
120 k€ |
FOI |
| FP7:SEC |
AIRBEAM |
11-14 |
500 k€ |
FOI |
| FP7:SEC |
Alert4All |
11-14 |
620 k€ |
FOI |
| FP7:SEC |
ETCETERA |
11-14 |
360 k€ |
FOI |
| FP7:SEC |
SEREN2 |
11-14 |
20 k€ |
FOI |
| FP7:SEC |
PRACTICE |
11-14 |
825 k€ |
FOI |
| FP7:ICT |
SAFECITY |
11-14 |
304 k€ |
FOI |
| FP7:ICT |
NANOTEC |
11-14 |
300 k€ |
FOI |
| FP7:SEC |
FIDELITY |
12-14 |
687 k€ |
FOI |
| FP7:SEC |
HYPERION |
12-14 |
902 k€ |
FOI |
| FP7:SEC |
D-BOX |
12-14 |
750 k€ |
FOI |
| FP7:SEC |
XP-DITE |
12-14 |
1133 k€ |
FOI |
| FP7:SEC |
SAFEPOST |
12-14 |
780 k€ |
FOI |
| FP7:SEC |
ETTIS |
12-14 |
300 k€ |
FOI |
| FP7:SEC |
INNOSEC |
12-14 |
165 k€ |
FOI |
| FP7:AAT |
Man4Gen |
12-15 |
436 k€ |
LiU |
| FP7:SEC |
ENCOUNTER |
12-15 |
745 k€ |
FOI |
| FP7:SEC |
SUBCOP |
13-16 |
870 k€ |
FOI |
| FP7:SEC |
P5 |
13-16 |
982 k€ |
FOI |
| FP7:ICT |
Graphene Flagship |
13-16 |
600 k€ |
LiU |
| FP7:SEC |
EUROSKY |
13-17 |
941 k€ |
FOI |
| FP7:ICT |
SHERPA |
13-17 |
1025 k€ |
LiU |
| FP7:SEC |
COURAGE |
14-16 |
103 k€ |
FOI |
| FP7:SEC |
AF3 |
14-17 |
185 k€ |
LiU |
| FP7:SEC |
VALCRI |
14-17 |
861 k€ |
LiU |
| FP7:SEC |
SECTOR |
14-17 |
373 k€ |
FOI |
| FP7:SEC |
IPATCH |
14-17 |
400 k€ |
FOI |
| FP7:SEC |
EXPEDIA |
14-17 |
1193 k€ |
FOI |
| FP7:SEC |
CONSORTIS |
14-17 |
394 k€ |
FOI |
| FP7:SEC |
INACHUS |
14-16 |
680 k€ |
FOI |
| FP7:SEC |
DRIVER |
14-18 |
214 k€ |
FOI |
| FP7:SEC |
CORE |
14-18 |
978 k€ |
FOI |
The Swedish Research Council (VR) funding in the consortium:
TITLE
|
YEARS
|
AMOUNT (SEK)
|
ORGANIZATION
|
| Statistical signal processing for comm. receivers |
09-11 |
4500 |
LiU |
| Wideband power-efficient Radio Frequency transmitters |
09-11 |
2290 |
LiU |
| CMOS sampling radio |
09-11 |
2290 |
LiU |
| Linnaeus EC CADICS |
08-17 |
18000 |
LiU |
| “Now-casting” of infectious disease outbreaks |
09-11 |
1950 |
LiU |
| Integrated THz Sources |
09-11 |
2292 |
Chalmers |
| Embodied visual object recognition |
09-12 |
4316 |
LiU |
| Groups and manifolds for information processing |
09-11 |
2100 |
LiU |
| Extended Target Tracking |
11-14 |
9600 |
LiU |
FORMAS funding in the consortium:
TITLE
|
YEARS
|
AMOUNT
|
ORGANIZATION
|
| Microelectrode arrays for drinking water quality monitoring |
11-13 |
4412 |
LiU |
MSB funding in the consortium:
TITLE
|
YEARS
|
AMOUNT
|
ORGANIZATION
|
| Professorship in Emergency Response |
09-13 |
12500 |
LiU |
| Assessing public acceptance of privacy invasive ICT solutions |
08-11 |
3315 |
KTH |
| CEREX |
10-11 |
4000 |
FOI |
| ISSI |
10-13 |
13000 |
FOI, Chalmers |
| CopeTech-Coping with technology changes |
07-11 |
|
FOI, KTH |
VINNOVA funding in the consortium:
TITLE
|
YEARS
|
AMOUNT
|
ORGANIZATION
|
| Practical algorithms for cooperation in wireless networks |
08-11 |
4500 |
LiU |
| Modulation and coding techniques, spectrum and propagation |
08-11 |
1561 |
LU, LiU |
| DETEX (jointly with MSB and FMV) |
08-11 |
6000 |
FOI |
| EC LINK-SIC |
08-17 |
18000 |
LiU |
| IKT för snabba beslut om farliga ämnen |
10-11 |
1371 |
FOI |
| FOCUS Phase 2 |
10-12 |
19200 |
FOI, LiU, Chalmers |
| Forum Securitatis Phase 2 |
10-12 |
5000 |
FOI, LiU |
| SISS-Sensor Informatics in Security && Safety |
11-13 |
2400 |
FOI, LiU |
| ACTRESS -Activity and Threat Recognition for Safe. & Sec. |
10-13 |
2400 |
FOI |
| Human Finder |
11-14 |
150 k€ |
FOI |
SSF funding in the consortium:
TITLE
|
YEARS
|
AMOUNT
|
ORGANIZATION
|
| Framtidens forskningsledare (Erik G Larsson) |
08-13 |
8500 |
LiU |
| Algorithms and architectures for baseband signal processing |
08-11 |
8300 |
LiU |
| Flexible and low-power wireless transceiver platforms |
08-12 |
20000 |
LiU |
| RAMCOORAN |
09-13 |
5085 |
KTH, LiU |
| DSP plattform f¿or framtida telekommunikation och multimedia |
08-11 |
12500 |
LiU |
| EC MOVIII |
06-11 |
9000 |
LiU |
| Grafenbaserad THz elektronik |
08-11 |
4000 |
Chalmers |
| ProInstitute |
10-12 |
3600 |
FOI, LiU |
| Collaborative autonomous robotics |
11-16 |
15000 |
LiU |
| Cooperative localization |
11-16 |
18000 |
LiU |
Industrial Research Contracts:
TITLE
|
YEARS
|
AMOUNT
|
ORGANIZATION
|
| Behovsanalys & övergripande systemdesign för utveckling av fysiskt skydd för SKBs nya fartyg (fas 2)(SKB) |
11 |
990 |
FOI |
| Cyber Security |
11 |
100 |
FOI |
Good soundness is a result of good soundness care and lifestyle. How can medicaments hels up? Today the assortment you can order from online pharmacy is real high. For example Antabuse is used in given folk with chronic alcoholism. Creates an distasteful reaction when drinking alcohol, which reduces the desire to drink. Cialis is a prescription drug used to treat impotency. If you’re concerned about erectile disease, you perhaps know about canadian pharmacy cialis 20mg and . Where you can get more information about ? (Read more ). At present more than half of men aged over 50 reported some degree of erectile dysfunctions. A medical review found that about 14 percent of patients capture Zyban reported sexual disfunction. If you choose to order remedies like Cialis online, always visit your sex therapist before do it. Very likely your physician will take into account possible remedy interactions with Cialis, your age and any previous experience you have had with the treatment.
